DrugPatentWatch Database Preview
SODIUM POLYSTYRENE SULFONATE - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for sodium polystyrene sulfonate and what is the scope of patent protection?
Sodium polystyrene sulfonate
is the generic ingredient in five branded drugs marketed by Kvk Tech, Concordia, Paddock Llc, Belcher, Citrusphrma, Cmp Pharma Inc, Eci Pharms Llc, Epic Pharma Llc, Novelgenix Theraps, Nuvo Pharms Inc, Wockhardt, Hikma, Morton Grove, and Roxane, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.There are one thousand four hundred and seventy-two drug master file entries for sodium polystyrene sulfonate. Fifteen suppliers are listed for this compound.
Summary for SODIUM POLYSTYRENE SULFONATE
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 14 |
| NDAs: | 17 |
| Drug Master File Entries: | 1472 |
| Suppliers / Packagers: | 15 |
| Bulk Api Vendors: | 33 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,746 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for SODIUM POLYSTYRENE SULFONATE |
| DailyMed Link: | SODIUM POLYSTYRENE SULFONATE at DailyMed |
Recent Clinical Trials for SODIUM POLYSTYRENE SULFONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tris Pharma, Inc. | Phase 4 |
| Weill Medical College of Cornell University | Phase 4 |
| The Rogosin Institute | Phase 4 |
US Patents and Regulatory Information for SODIUM POLYSTYRENE SULFONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 088717-001 | Sep 11, 1984 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Paddock Llc | KIONEX | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 040028-001 | Sep 17, 2007 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Roxane | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 088453-001 | Nov 17, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Epic Pharma Llc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 202333-001 | Mar 19, 2014 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
